Ciprofloxacin resistance among nosocomial Pseudomonas aeruginosa and Staphylococcus aureus in the United States. [electronic resource]
- Infection control and hospital epidemiology Feb 1995
- 71-5 p. digital
Publication Type: Journal Article
0899-823X
10.1086/647059 doi
Ciprofloxacin--pharmacology Cross Infection--microbiology Drug Resistance, Microbial Humans Microbial Sensitivity Tests Pseudomonas aeruginosa--drug effects Risk Factors Staphylococcus aureus--drug effects Time Factors United States